Literature DB >> 30225330

Widespread hyperpigmented rash present for 1 year.

Carly Dunn1, Danielle S Applebaum1, Harry Dao1.   

Abstract

Entities:  

Keywords:  erythrasma; general dermatology; medical dermatology

Year:  2018        PMID: 30225330      PMCID: PMC6138843          DOI: 10.1016/j.jdcr.2018.04.012

Source DB:  PubMed          Journal:  JAAD Case Rep        ISSN: 2352-5126


× No keyword cloud information.
A 59-year-old woman with type II diabetes mellitus and obesity presented to the clinic for evaluation of a hyperpigmented rash located in her axillae, groin, buttock, umbilicus, and inframammary region (Fig 1, Fig 2, Fig 3, Fig 4, Fig 5, Fig 6) of 1 years' duration. She reported pruritus and occasional fissuring after scratching. She was treated previously with nystatin powder, clotrimazole cream, and oral fluconazole for 4 weeks with minimal improvement.
Fig 1
Fig 2
Fig 3
Fig 4
Fig 5
Fig 6
Question 1: What is the diagnosis? Mycosis fungoides Inverse psoriasis Dermatophytosis Erythrasma Candidiasis Answers: Mycosis fungoides – Incorrect. Mycosis fungoides classically appears as patches. It takes years to develop and most cases occur in whites (70%; Hispanics, 9%). Inverse psoriasis – Incorrect. Inverse psoriasis presents with erythematous, shiny, moist plaques in intertriginous areas but with no scale.2, 3 Dermatophytosis – Incorrect. Dermatophytosis often occurs with onychomycosis; lack of response to antifungals makes this diagnosis less likely. Erythrasma – Correct. Erythrasma presents with erythematous to tan, asymptomatic or pruritic scaly plaques in intertriginous areas and is caused by Corynebacterium minutissimum.5, 6 Risk factors include obesity, poor hygiene, warm climate, and diabetes mellitus. Candidiasis – Incorrect. Candidiasis has satellite papules and would have improved with antifungals. Question 2: What does Wood's lamp detect in this patient? Coproporphyrin III Melanin Rhodopsin Carotenoid Pyocyanin Answers: Coproporphyrin III – Correct. Diagnosis of erythrasma can be made easily by Wood's lamp examination, which characteristically fluoresces coral red due to coproporphyrin III.5, 8 Melanin – Incorrect. Wood's lamp does not detect melanin, the naturally occurring pigment in skin and hair. Rhodopsin – Incorrect. Wood's lamp does not detect rhodopsin, which is the purple pigment in eyes that helps with sight in dim light. Carotenoid – Incorrect. Wood's lamp does not detect these red, yellow, or orange pigments, such as carotene, which give color to plant parts such as carrots or fall leaves. Pyocyanin – Incorrect. Wood's lamp does not detect this blue-green pigment, which gives pseudomonas its characteristic color. Question 3: How would you treat this patient? Topical steroids Macrolide antibiotic Immunotherapy Topical antifungals Barrier cream Answers: Topical steroids – Incorrect. Topical steroids would be used for a diagnosis of inverse psoriasis and are not indicated for erythrasma, as it is a bacterial infection. Macrolide antibiotic – Correct. Erythrasma is treated with topical clindamycin, erythromycin, or antibacterial soaps, such as benzoyl peroxide. For recalcitrant or extensive disease, a 5- to 14-day course of oral erythromycin or clarithromycin is used to eliminate the corynebacterium. For therapeutic failure of intertriginous involvement, topical clindamycin or other antibacterial soaps are added. Immunotherapy – Incorrect. Immunotherapy can be used for cutaneous malignancies, such as mycosis fungoides; however, immunotherapy is not used for the treatment of erythrasma. Topical antifungals – Incorrect. The patient has not responded to topical and oral antifungals, and these are not indicated in the treatment of erythrasma. Barrier cream – Incorrect. Barrier creams are typically used to treat dermatitis and dry skin and work to improve barrier function of the skin and reduce its susceptibility to irritants.

Discussion

This article represents an interesting presentation of extensive erythrasma, which required a biopsy for diagnosis. This case highlights the importance of keeping erythrasma on the differential diagnosis of a rash in the intertriginous areas, especially as it can be easily identified with Wood's Lamp in the office.
  9 in total

1.  Inverse psoriasis: case presentation and review.

Authors:  Zain U Syed; Amor Khachemoune
Journal:  Am J Clin Dermatol       Date:  2011-04-01       Impact factor: 7.403

2.  The etiology and treatment of erythrasma.

Authors:  I SARKANY; D TAPLIN; H BLANK
Journal:  J Invest Dermatol       Date:  1961-10       Impact factor: 8.551

3.  An atypical presentation of erythrasma.

Authors:  Barbara B Wilson; Aubrey Wagenseller; Mary-Margaret B Noland
Journal:  J Am Acad Dermatol       Date:  2012-11       Impact factor: 11.527

4.  Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm).

Authors:  M Lodén; A C Andersson; M Lindberg
Journal:  Br J Dermatol       Date:  1999-02       Impact factor: 9.302

Review 5.  Psoriasis inversa: A separate identity or a variant of psoriasis vulgaris?

Authors:  Silje Haukali Omland; Robert Gniadecki
Journal:  Clin Dermatol       Date:  2015-04-08       Impact factor: 3.541

Review 6.  Management of cutaneous erythrasma.

Authors:  Mack R Holdiness
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Exogenous coproporphyrin III production by Corynebacterium aurimucosum and Microbacterium oxydans in erythrasma lesions.

Authors:  Ayako Yasuma; Toyoko Ochiai; Motoki Azuma; Hiroyuki Nishiyama; Ken Kikuchi; Masao Kondo; Hiroshi Handa
Journal:  J Med Microbiol       Date:  2011-03-10       Impact factor: 2.472

Review 8.  Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.

Authors:  Sarah I Jawed; Patricia L Myskowski; Steven Horwitz; Alison Moskowitz; Christiane Querfeld
Journal:  J Am Acad Dermatol       Date:  2014-02       Impact factor: 11.527

9.  Clinical, epidemiological, and therapeutic profile of dermatophytosis.

Authors:  Carla Andréa Avelar Pires; Natasha Ferreira Santos da Cruz; Amanda Monteiro Lobato; Priscila Oliveira de Sousa; Francisca Regina Oliveira Carneiro; Alena Margareth Darwich Mendes
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.